Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.[2][3][4]

See also

References

  1. ^ Webster NR, Galley HF (22 August 2013). Landmark Papers in Anaesthesia. OUP Oxford. pp. 70–. ISBN 978-0-19-163319-5.
  2. ^ Acta anaesthesiologica Belgica. Acta Medica Belgica. 1974.
  3. ^ Klein SL (1993). A glossary of anesthesia and related terminology. Springer-Verlag. ISBN 978-0-387-97831-4.
  4. ^ Catcott EJ, Smithcors JF (1973). Progress in canine practice. American Veterinary Publications.



Allikas: http://en.wikipedia.org/wiki/Halopropane
No tags for this post.